This trial will assess whether RGH patients who have two recurrent episodes within a three month period would benefit from suppressive treatment and whether patients prefer episodic therapy or suppressive therapy for the treatment of their RGH.

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

A Study to Determine the Safety and Efficacy of Famciclovir in the Episodic and Suppressive Treatment of Recurrent Genital Herpes (RGH). The Study Will Also Evaluate Quality of Life and Patient Satisfaction

Treatment Trials

Focus your search

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

Description

Conditions